Blanchard Cheryl R
- SEC CIK
- 0001326530
No open-market purchases or sales filed in the past year.
Current role at each company
- XLO Xilio Therapeutics, Inc.Directoras of Apr 16, 2026
- ANIK Anika Therapeutics, Inc.Directoras of Mar 17, 2026
- VIGL Vigil Neuroscience, Inc.Directoras of Aug 5, 2025
- DARE Dare Bioscience, Inc.Directoras of Jun 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Blanchard Cheryl R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANIK Anika Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Blanchard Cheryl RPresident, CEO, Director | PPurchase | +8.10K | $25.57 | +$207.1K | +15.6%60.0K after | 2 lots |